Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Supportive Care in Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00520-015-2762-1PMID 25980681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.

  2013cited by this paper
• C‐reactive protein as a prognostic marker for advanced renal cell carcinoma treated with sunitinib

  2012cited by this paper
• Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation

  2011cited by this paper
• Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.

  2009cited by this paper
• High-dose daunorubicin in older patients with acute myeloid leukemia.

  2009cited by this paper
• Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia.

  2007cited by this paper
• Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

  2007cited by this paper
• Septic shock; current pathogenetic concepts from a clinical perspective. Adelais G. Tsiotou, George H. Sakorafas, George Anagnostopoulos, John Bramis Med Sci Monit, 2005; 11(3): RA76-85.

  2006cited by this paper
• Acute myeloid leukaemia.

  2006cited by this paper
• Septic shock; current pathogenetic concepts from a clinical perspective.

  2005cited by this paper
• A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Adult acute myeloid leukaemia.

  2004cited by this paper
• Serum Ferritin Levels in Poorly‐ and Well‐Controlled Diabetes Mellitus

  2003cited by this paper
• Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator

  2003cited by this paper
• The role of C-reactive protein as a prognostic indicator in advanced cancer

  2002cited by this paper
• C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging.

  2001cited by this paper
• Therapeutic options for acute myelogenous leukemia

  2001cited by this paper
• C-reactive protein: linking inflammation to cardiovascular complications.

  2001cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance.

  2000cited by this paper
• Acute-phase proteins and other systemic responses to inflammation.

  1999cited by this paper
• Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.

  1998cited by this paper
• Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer.

  1998cited by this paper
• Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

  1997cited by this paper
• Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons.

  1996cited by this paper
• The use of serum ferritin to identify good and bad prognosis groups in acute myeloid leukemia.

  1984cited by this paper
• ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.4.368 Elevation of Serum Ferritin is Associated with the Outcome of Patients with Newly Diagnosed Multiple Myeloma

  year unknowncited by this paper

• Impact of Serum Ferritin and Iron Overload on Acute Myeloid Leukemia Outcomes: A Systematic Review and Meta-Analysis

  2024cites this paper
• LncRNA TMPO-AS1 Promotes Triple-Negative Breast Cancer by Sponging miR-383-5p to Trigger the LDHA Axis

  2024cites this paper
• Prognostic value of Elevated Serum Inflammatory Markers in Adult Patients receiving Induction Chemotherapy for Acute Leukemia

  2022influential citation
• Treatment-Related Mortality From Infectious Complications in an Acute Leukemia Clinic

  2020cites this paper
• The detection of bacterial infections in leukemia patients using procalcitionin levels

  2020cites this paper
• Simple acute phase protein score to predict long‐term survival in patients with acute myeloid leukemia

  2019cites this paper
• Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma

  2019cites this paper
• Development of a simplified multivariable model to predict neutropenic complications in cancer patients undergoing chemotherapy

  2018cites this paper